Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Winning cash for taking blood pressure meds increases compliance
About 71% of patients in the rewards group opened their blood pressure medication on 80% of days, compared with about 34% in the control group.
Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial
The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.
SCAI: To improve cardiogenic shock outcomes, reduce lactate levels
SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data.
Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO
The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.

Surgery still more common than TMVR among AMI patients, but the gap is shrinking

The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy.

Report reveals plausibility that COVID-19 leaked from Wuhan lab

A new report reveals that it’s plausible the COVID-19 leaked from a Wuhan lab, giving other calls for investigation into the origin of the virus new life.

Abbott prepared for influx of new patients in wake of Medtronic’s announcement, FDA’s recommendation

In a recent advisory, the FDA specifically mentioned Abbott's HeartMate 3 LVAD as an effective alternative to Medtronic's HVAD system.

Presenting with additional chronic conditions can make a big impact on TAVR outcomes

Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.

Athletes fully recover from COVID-19 with no long-term heart damage

“Our results show that none of the athletes who underwent cardiac MRI had abnormal findings," one researcher explained.

How later COVID-19 surges impacted heart attack and stroke numbers

This new analysis helps paint a better picture of how COVID-19 has affected patient care in the United States.

Medtronic stops sales and distribution of HVAD system due to multiple issues, including 14 patient deaths

The device's internal pump was associated with a heightened risk of adverse outcomes, including stroke and death.

LAAO during cardiac surgery helps AFib patients reduce stroke risk

AFib patients undergoing cardiac surgery may benefit from concomitant LAAO, according to a new study in the New England Journal of Medicine.

Clinical

Winning cash for taking blood pressure meds increases compliance

Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial

New physician Medicare payments for the Agent drug-coated balloon set for 2027

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels

Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO